Post COVID-19 Organizing Pneumonia: The Right Time to Interfere

Medicina

Kristina Bieksiene¹  Kestutis Malakauskas¹  Skaidrius Miliauskas¹  Neringa Vaguliene¹  Marius Zemaitis¹  Jurgita Zaveckiene² 

[1] Department of Pulmonology, Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania;Department of Radiology, Lithuanian University of Health Sciences, 44307 Kaunas, Lithuania;

关键词: COVID-19;    viral pneumonia;    organizing pneumonia;    systemic glucocorticoids;    interstitial lung diseases;   

DOI  :  10.3390/medicina57030283

来源: DOAJ

【 摘 要 】

The COVID-19 pandemic dramatically changed medical care. Healthcare professionals are faced with new issues. Patients who survived COVID-19 have plenty of different continuing symptoms, of which the most common are fatigue and breathlessness. It is not well known how to care for patients with persistent or worsening respiratory symptoms and changes on chest X-ray following COVID-19 pneumonia. In this article, we talk about a subgroup of patients with organizing pneumonia following COVID-19 pneumonia that could be effectively treated with systemic glucocorticoids. It is important that patients with COVID-19 pneumonia be followed-up at least three weeks after diagnosis, in order to recognize early lung damage. We are providing a management algorithm for early diagnosis of lung diseases after COVID-19 pneumonia.

【 授权许可】

Unknown